French Prospective Observational Study in Patients Eligible for Systemic Therapy for Atopic Dermatitis (AD)

Investigating Treatment Management in Adults with Atopic Dermatitis

Recruiting
18 years or above
All
Phase N/A
600 participants needed
1 Location

Study Overview

The objective of the study is to describe the therapeutic management of patients more than or equal to 18 years old eligible for systemic therapy or treated by systemic therapy for atopic dermatitis (AD). This study will be proposed to a sample of French dermatologists experienced in the management of AD, practicing in hospital centers and/or office-based dermatologists. The study will be conducted in real conditions of practice, systemic treatment decisions will be taken at the sole initiative of the participating physician irrespective of the patient enrollment decision. Each patient will be followed-up in routine care setting for 1 year.

Eligibility Criteria

You may be eligible for this study if you meet the following criteria:

  • Conditions: Atopic Dermatitis
  • Age: 18 years or above
  • Gender: All

Inclusion Criteria:

  • Signed informed consent form.
  • Patient with moderate to severe AD according to the Investigator's judgment and
    1. Patient eligible to systemic treatment as Atopic Dermatitis Control Tool (ADCT) more than or equal to (≥) 7 and/or use topical corticosteroids (TCS) more than (>) 90 gram (g)/month and/or TCS are not advisable.

      or

    2. Patient currently under systemic treatment.
  • Able to understand and complete study-related questionnaires.

Exclusion Criteria:

  • Any condition that, in the opinion of the Investigator, may interfere with patient's ability to participate in the study, such as short life expectancy, substance abuse, severe cognitive impairment, or other comorbidities that can predictably prevent the patient from adequately completing, as per routine care, the schedule of visits and assessments
  • Patient receiving systemic therapy only for a disease other than AD.
  • Patient participating in any interventional clinical trial at the time of enrolment.
  • Patient is under tutorship or curatorship; patient under safeguard of justice or deprived of his/her liberty by an administrative or court decision

Updated on 20 Feb 2025. Study ID: NCT06837454

This study investigates the management of adults with atopic dermatitis (AD) who are eligible for or currently receiving systemic therapy. Atopic dermatitis is a chronic skin condition characterized by itchy, inflamed skin. The purpose of this study is to observe how systemic treatments are used in real-life settings by French dermatologists, either in hospitals or private practices.

Participants will be followed for one year as part of their regular care. The study does not interfere with the treatment decisions made by physicians. Participants may be asked to complete questionnaires to help researchers understand the effectiveness of their treatments.

  • Who can participate: Adults aged 18 and older with moderate to severe atopic dermatitis can participate if they are eligible for systemic treatment or are already receiving it. Participants must be able to understand and complete study questionnaires.
  • Study details: Participants will continue their usual care with their dermatologist, who will decide on systemic treatments as needed. They may complete questionnaires about their condition and treatment. Systemic treatments are medications that work throughout the body to control atopic dermatitis symptoms.
  • Study timelines: The study will last 1 year.

Find a study site near you

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
United States Only: Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language